Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
11.52
-0.01 (-0.09%)
At close: Jul 25, 2025, 4:00 PM
11.52
0.00 (0.02%)
After-hours: Jul 25, 2025, 5:18 PM EDT
Nurix Therapeutics Market Cap
Nurix Therapeutics has a market cap or net worth of $880.70 million as of July 25, 2025. Its market cap has decreased by -32.39% in one year.
Market Cap
880.70M
Enterprise Value
446.85M
1-Year Change
-32.39%
Ranking
Category
Stock Price
$11.52
Market Cap Chart
Since July 24, 2020, Nurix Therapeutics's market cap has increased from $704.09M to $880.70M, an increase of 25.08%. That is a compound annual growth rate of 4.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 880.70M | -34.01% |
| Dec 31, 2024 | 1.33B | 166.61% |
| Dec 29, 2023 | 500.56M | -3.31% |
| Dec 30, 2022 | 517.68M | -59.92% |
| Dec 31, 2021 | 1.29B | 1.09% |
| Dec 31, 2020 | 1.28B | 81.45% |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 717.19B |
| Johnson & Johnson | 406.87B |
| AbbVie | 336.59B |
| Novo Nordisk | 309.02B |
| UnitedHealth Group | 265.35B |
| Novartis AG | 227.08B |
| AstraZeneca | 224.54B |
| Abbott Laboratories | 218.92B |